Researcher.Life Logo

Acta Haematologica : Impact Factor & More

eISSN: 1421-9662pISSN: 0001-5792

Key Metrics

CiteScore
3.7
H-Index
60
Impact Factor
< 5
SJR
Q2Hematology
SNIP
0.92
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Acta Haematologica

Acta Haematologica Journal Specifications

Overview
Publisher KARGER
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1948
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Acta Haematologica ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Acta Haematologica

Efficacy of second-generation FLT3 inhibitors in FLT3-mutated AML: A meta-analysis of randomized controlled trials.
  • 19 Jun 2026
  • Acta haematologica
Limited prognostic value of ELN classification and relevance of molecular ontogeny in acute myeloid leukemia post myeloproliferative neoplasms: a retrospective multicenter study.
  • 15 Jun 2026
  • Acta haematologica
Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data Collection.
  • 12 Jun 2026
  • Acta haematologica
COVID-19 infection in patients with follicular lymphoma and related indolent B-cell lymphomas receiving anti-CD20 monoclonal antibody maintenance therapy.
  • 8 Jun 2026
  • Acta haematologica
Comparative efficacy of donor lymphocyte infusions in augmenting graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies.
  • 8 Jun 2026
  • Acta haematologica
Shared Care Offers an Effective Framework for Managing Tagraxofusp Treatment in Blastic Plasmacytoid Dendritic Cell Neoplasm.
  • 4 Jun 2026
  • Acta haematologica
Efficacy of second-generation FLT3 inhibitors in FLT3-mutated AML: A meta-analysis of randomized controlled trials.
  • 19 Jun 2026
  • Acta haematologica
Limited prognostic value of ELN classification and relevance of molecular ontogeny in acute myeloid leukemia post myeloproliferative neoplasms: a retrospective multicenter study.
  • 15 Jun 2026
  • Acta haematologica
Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data Collection.
  • 12 Jun 2026
  • Acta haematologica
COVID-19 infection in patients with follicular lymphoma and related indolent B-cell lymphomas receiving anti-CD20 monoclonal antibody maintenance therapy.
  • 8 Jun 2026
  • Acta haematologica
Comparative efficacy of donor lymphocyte infusions in augmenting graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies.
  • 8 Jun 2026
  • Acta haematologica
Shared Care Offers an Effective Framework for Managing Tagraxofusp Treatment in Blastic Plasmacytoid Dendritic Cell Neoplasm.
  • 4 Jun 2026
  • Acta haematologica

FAQs on Acta Haematologica